PASG
Passage Bio Inc
NASDAQ: PASG · HEALTHCARE · BIOTECHNOLOGY
$5.11
-4.49% today
Updated 2026-04-30
Market cap
$18.32M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-14.35
Dividend yield
—
52W range
$5 – $20
Volume
0.1M
Passage Bio Inc (PASG) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-18.57M | $-39.90M | $-80.52M | $-126.88M | $-118.21M | $-78.26M | $-47.96M | $-31.51M |
| Capital expenditures | $2.54M | $1.69M | $1.65M | $25.64M | $5.27M | $146000.00 | $34000.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — |
| Stock-based comp | — | $1.45M | $14.58M | $32.69M | $18.95M | $10.92M | $5.82M | $3.00M |
| Free cash flow | $-21.11M | $-41.59M | $-82.17M | $-152.52M | $-123.48M | $-78.41M | $-47.99M | $-31.51M |
| Investing cash flow | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $-23.87M | $-6.04M | $-94.36M | — | — | — |